Bleeding out: a year of glp-1s, endometriosis, and a mother's unexpected help
For nearly two years, my life was defined by a relentless, unending period. It wasn’t the predictable inconvenience of a monthly cycle; it was a constant, bleeding reality – a testament to a battle waged within my own body.
A diagnosis that wasn’t
The diagnosis of endometriosis felt less like a revelation and more like a frustrating detour. After months of debilitating bleeding, an initial ultrasound and a frustrating appointment with a new endocrinologist led to a blunt suggestion: lose weight. The sheer audacity of it – to prescribe a starvation diet as a solution to a complex hormonal issue – was staggering. Frankly, it felt like a dismissive refusal to acknowledge the years I’d spent grappling with disordered eating and the deeply personal nature of my struggles.
The unexpected intervention
Then came the surprising twist: my mother stepped in, offering to cover the cost of Zepbound, a GLP-1 medication. It wasn’t a grand gesture, but a lifeline. Initially, I hesitated, wrestling with the uncomfortable feeling of needing her support, a stark contrast to the fiercely independent image I’d cultivated. But the truth was, I didn’t have the funds, and the prospect of continuing to navigate this healthcare labyrinth alone felt…well, suffocating.
A shifting landscape
The initial 50-pound goal materialized, and with it, a return to a more ‘normal’ menstrual cycle. But the victory felt strangely bittersweet. The doctor’s fatphobic advice – a simple ‘lose weight’ – had inadvertently worked, yet it left a lingering unease. Was this a genuine triumph, or simply a shortcut, a way to sidestep the harder work of truly understanding and accepting my body?
Beyond the scale
I’ve lost nearly 50 pounds, and my period has finally settled into a predictable rhythm. Yet, I’m grappling with the implications. Am I chasing a phantom ideal of thinness, perpetuating the very narrative I fought so hard to dismantle? And is relying on a pharmaceutical intervention truly a liberation, or merely a temporary reprieve from a far deeper, more complex issue?
A nuance worth noting
The rush to embrace GLP-1s needs a critical lens. While I’ve experienced minimal side effects and maintained my appetite – a stark contrast to some – the broader implications for the way these drugs are marketed, especially the emphasis on weight loss as the primary benefit, are deeply concerning. Access to affordable healthcare shouldn’t be contingent on conforming to an arbitrary standard of beauty. It's a shame that Lilly, the manufacturer, seems largely indifferent to the individual struggles of patients like me.
Moving forward
I don’t claim to have all the answers. My journey with Zepbound is ongoing, and I’m wary of becoming a poster child for weight loss. But one thing is certain: acknowledging the complexities of my health – and accepting the support of my mother – has been a crucial step. Perhaps the most valuable lesson isn't about shedding pounds, but about confronting the uncomfortable truths about our relationship with our bodies and the systems that shape them.